TGen and the University of Pennsylvania (Penn) have received a three-year, $18 million grant from Stand Up to Cancer (SU2C) to research pancreatic cancer.
Dr. Daniel Von Hoff, TGen’s Physician-In-Chief, and Dr. Craig B. Thompson, Director of the Abramson Cancer Center at Penn, are co-leaders of SU2C’s pancreatic cancer “Dream Team,’’ which will investigate
TGen and UC Berkeley scientists use ‘pooled’ method to discover gene associated with non-Hodgkin lymphoma
Follicular lymphoma accounts for as much as 30 percent of all non-Hodgkin lymphoma (NHL), a cancer of the lymphatic system involving the blood, bone marrow and lymph nodes.
It was a little outside of his scientific comfort zone, but TGe
1000 Genomes Project provides an in-depth look across multiple genomes
A new international effort – the 1000 Genomes Project – aims to sequence, or spell out, the complete genomes of more than 1,000 individuals, establishing by far the most detailed catalogue of human genetic variation as a tool for medical research.
In 2003, after 13 years
Drug used in stroke patients may reduce risk of Alzheimer's disease; improve learning and memory
A drug used to improve blood flow to the brain also could help improve learning and memory and reduce the risk of Alzheimer's disease, according to a recent study by investigators at TGen, Arizona State University and the Arizona Alzheimer's Consortium.
TGen's Dr. Haiyong Han is inspired by patients’ stories in his quest to find a cure for the most deadly of all cancers.
At first, Dr. Haiyong Han's scientific journey was a series of intuitively logical steps, starting from his hometown of Shaoxing, one of China's most culturally and historically significant cities.
But in more recent years, his e
Doctor thrives in dual role as TGen cancer researcher and medical school faculty
In her dual role as a TGen investigator and a medical school instructor, it is not enough for Dr. Suwon "Sue" Kim to simply teach.
She wants her doctors-in-training to go beyond memorizing texts and jump into research riddles.
"I like solving puzzles," said Kim, who
A Personal Journey Leads to A Career in Research
If he wasn’t a scientist, TGen’s Dr. Nhan Tran says he might be on Wall Street looking for the “next big thing” or in corporate law asking, “What are the facts?”
But in his role as Associate Investigator in TGen’s Brain Tumor Research Lab, Dr. Tran has the opportunity to ask — and hopefully answer—
A team of investigators led by scientists at the Translational Genomics Research Institute (TGen) have found a way to identify possible suspects at crime scenes using only a small amount of DNA, even if it is mixed with hundreds of other genetic fingerprints. Using genotyping microarrays, the scientists were able to identify an individual's DNA from within a mix of DNA samples...